JP TSE 190A Pharmaceutical

Chordia Therapeutics,Inc

Ｃｈｏｒｄｉａ　Ｔｈｅｒａｐｅｕｔｉｃｓ株式会社

Net income

−¥1.8B

≈ −$11.3M

Income taxes paid

¥2.4M

≈ $15K

Total assets

¥2.7B

≈ $17.0M

Equity ratio

90.9%

Ranked #3,920 among listed Japanese companies by corporate taxes paid.

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Aug 2025	—	−¥1.8B	¥2.4M	¥2.4M	¥2.7B	¥2.4B	90.9%	EDINET
Aug 2024	—	−¥1.8B	¥2.4M	¥2.4M	¥4.6B	¥4.2B	89.8%	EDINET
Aug 2023	—	¥223M	—	—	¥4.9B	¥4.5B	91.7%	EDINET
Aug 2022	—	−¥1.8B	—	—	¥4.5B	¥4.3B	95.1%	EDINET
Aug 2021	—	−¥527M	—	—	¥2.3B	¥2.1B	90.5%	EDINET

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.